NEW YORK, Nov. 17, 2023 /PRNewswire/ — The companion animal specialty drugs market measurement is anticipated to develop by USD 4.55 billion from 2023 to 2028. In addition, momentum of the market will progress at a CAGR of 6.68% through the forecast interval, in accordance with Technavio Research. The market is segmented by distribution channel (veterinary hospitals, pet care clinics, and pharmacy shops), product (Vaccines, Antibiotics, Parasiticides, Feed components, and Others), and geography (North America, Europe, Asia, and Rest of World (ROW)). North America is estimated to contribute 35% to the expansion of the worldwide market throughout the forecast interval. The US, Canada, and Mexico are among the most vital nations which have a significant impression on market progress in North America. Furthermore, the adoption fee of pets is on the rise as increasingly elderly individuals search companionship.
This report presents an up-to-date evaluation of the present market situation, the latest traits and drivers, and the general market setting. Read a Free PDF Sample Report
Company Profile:
Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Orion Corp.
-
Bayer AG: The firm focuses on companion animal specialty medicine by proteins which might be contained in milk, eggs, and meat.
To access extra firm profiles available with Technavio, buy the report!
Companion Animal Specialty Drugs Market: Segmentation Analysis
The veterinary hospitals phase is estimated to witness vital progress through the forecast interval. For companion animals, this phase gives a variety of veterinary companies. Grooming, vaccination, and flea therapy are among the elementary points of fine pet care.
Learn concerning the contribution of every phase summarized in concise infographics and thorough descriptions. View a PDF Sample Report
Companion Animal Specialty Drugs Market: Driver & Trend:
Key Drivers-
-
Increase in pet humanization
-
Rising consciousness about illness prevention and pet insurance coverage
-
Rise in ageing companion animal inhabitants
One of the important thing elements driving the companion animal specialty medicine is the rise within the ageing companion animal inhabitants. There is an upsurge within the elderly companion animal inhabitants throughout the globe because the homeowners of companion animals want to present correct vitamin to regulate ageing results. Also, the requirement for minerals and nutritional vitamins to assist rising dogs is sufficient for senior dogs.
A key issue shaping market progress is the rising weight problems in companion animals. Identify key traits, drivers, and challenges available in the market. Download a sample to gain access to this information.
Related Reports:
The erectile dysfunction (ED) drugs market is estimated to develop by USD 1.44 billion at a CAGR of 6.67% between 2023 and 2028.
The animal biotechnology market is estimated to develop by USD 3.65 billion at a CAGR of three.01% between 2023 and 2028.
What are the important thing information lined on this companion animal specialty medicine market report?
-
CAGR of the market through the forecast interval
-
Detailed info on elements that may drive the expansion of the companion animal specialty medicine market between 2023 and 2028.
-
Precise estimation of the companion animal specialty medicine market measurement and its contribution to the market in give attention to the guardian market
-
Accurate predictions about upcoming traits and adjustments in shopper conduct
-
Growth of the companion animal specialty medicine market throughout North America, Europe, Asia, and ROW
-
An intensive evaluation of the market’s aggressive panorama and detailed details about corporations
-
Comprehensive evaluation of things that may problem the expansion of companion animal specialty medicine market corporations.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Distribution Channel
Market Segmentation by Product
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a number one world know-how analysis and advisory firm. Their analysis and evaluation focuses on rising market traits and gives actionable insights to assist businesses establish market alternatives and develop efficient methods to optimize their market positions.
With over 500 specialised analysts, Technavio’s report library consists of greater than 17,000 stories and counting, masking 800 applied sciences, spanning throughout 50 nations. Their consumer base consists of enterprises of all sizes, together with greater than 100 Fortune 500 corporations. This rising consumer base depends on Technavio’s complete protection, intensive analysis, and actionable market insights to establish alternatives in present and potential markets and assess their aggressive positions inside altering market situations.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
View authentic content material to obtain multimedia:https://www.prnewswire.com/news-releases/companion-animal-specialty-drugs-market-to-grow-by-usd-4-55-billion-from-2023-to-2028-north-america-to-account-for-35-of-market-growth–technavio-301991610.html
SOURCE Technavio
